Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre 12-week Randomised, Double Blind, Placebo Controlled Trial of Simvastatin as Augmentation Treatment for Treatment-resistant Depression

NCT03435744 is registered in ClinicalTrials.gov with Pakistan Institute of Living and Learning as lead sponsor.

NCT NCT03435744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre 12-week Randomised, Double Blind, Placebo Controlled Trial of Simvastatin as Augmentation Treatment for Treatment-resistant Depression
Lead sponsor
Pakistan Institute of Living and Learning
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2019
Completion date
June 30, 2021
Enrollment
150 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, treatment resistant depression